IL187438D0 - Pyrrolopyridine derivatives and pharmaceutical compositions containing the same - Google Patents

Pyrrolopyridine derivatives and pharmaceutical compositions containing the same

Info

Publication number
IL187438D0
IL187438D0 IL18743807A IL18743807A IL187438D0 IL 187438 D0 IL187438 D0 IL 187438D0 IL 18743807 A IL18743807 A IL 18743807A IL 18743807 A IL18743807 A IL 18743807A IL 187438 D0 IL187438 D0 IL 187438D0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
pyrrolopyridine derivatives
pyrrolopyridine
Prior art date
Application number
IL18743807A
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US68355405P priority Critical
Priority to PCT/US2006/019711 priority patent/WO2006127587A1/en
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of IL187438D0 publication Critical patent/IL187438D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
IL18743807A 2005-05-20 2007-11-18 Pyrrolopyridine derivatives and pharmaceutical compositions containing the same IL187438D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US68355405P true 2005-05-20 2005-05-20
PCT/US2006/019711 WO2006127587A1 (en) 2005-05-20 2006-05-22 Pyrrolopyridines useful as inhibitors of protein kinase

Publications (1)

Publication Number Publication Date
IL187438D0 true IL187438D0 (en) 2008-02-09

Family

ID=36940144

Family Applications (1)

Application Number Title Priority Date Filing Date
IL18743807A IL187438D0 (en) 2005-05-20 2007-11-18 Pyrrolopyridine derivatives and pharmaceutical compositions containing the same

Country Status (16)

Country Link
US (1) US8921376B2 (en)
EP (3) EP1881983B1 (en)
JP (3) JP2008545660A (en)
KR (1) KR20080016659A (en)
CN (1) CN101228161B (en)
AT (1) AT540948T (en)
AU (1) AU2006251623A1 (en)
CA (1) CA2609126A1 (en)
ES (1) ES2380795T3 (en)
IL (1) IL187438D0 (en)
MX (1) MX2007014619A (en)
NO (1) NO20076502L (en)
NZ (1) NZ564065A (en)
RU (2) RU2435769C2 (en)
WO (1) WO2006127587A1 (en)
ZA (1) ZA200710379B (en)

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005062795A2 (en) 2003-12-19 2005-07-14 Plexxikon, Inc. Compounds and methods for development of ret modulators
KR101216372B1 (en) 2004-03-30 2013-01-04 버텍스 파마슈티칼스 인코포레이티드 Azaindoles useful as inhibitors of JAK and other protein kinases
US7498342B2 (en) 2004-06-17 2009-03-03 Plexxikon, Inc. Compounds modulating c-kit activity
WO2007013896A2 (en) 2005-05-17 2007-02-01 Plexxikon, Inc. Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
EP1881983B1 (en) * 2005-05-20 2012-01-11 Vertex Pharmaceuticals, Inc. Pyrrolopyridines useful as inhibitors of protein kinase
TWI522337B (en) 2005-06-22 2016-02-21 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
JP5071374B2 (en) 2005-07-14 2012-11-14 アステラス製薬株式会社 Heterocyclic Janus kinase 3 inhibitors
EP2251341A1 (en) * 2005-07-14 2010-11-17 Astellas Pharma Inc. Heterocyclic Janus kinase 3 inhibitors
US20070149506A1 (en) 2005-09-22 2007-06-28 Arvanitis Argyrios G Azepine inhibitors of Janus kinases
AU2015201850B2 (en) * 2005-12-13 2017-03-02 Incyte Holdings Corporation Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
MY159449A (en) * 2005-12-13 2017-01-13 Incyte Holdings Corp Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
JP2009521504A (en) * 2005-12-22 2009-06-04 スミスクライン・ビーチャム・コーポレイションSmithkline Beecham Corporation Akt activity inhibitor
AR060316A1 (en) 2006-01-17 2008-06-11 Vertex Pharma Azaindoles useful as inhibitors of Janus kinases
KR101081293B1 (en) * 2006-01-18 2011-11-08 에프. 호프만-라 로슈 아게 Thiazoles as 11 beta-hsd1 inhibitors
WO2007084667A2 (en) * 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Fused heterobicyclic kinase inhibitors
US8741912B2 (en) * 2006-04-05 2014-06-03 Vertex Pharmaceuticals Incorporated Deazapurines useful as inhibitors of Janus kinases
AU2007254179B2 (en) * 2006-05-18 2013-03-21 Pharmacyclics Llc Intracellular kinase inhibitors
CN101511842B (en) 2006-07-06 2012-10-31 阵列生物制药公司 Dihydrofuro pyrimidines as AKT protein kinase inhibitors
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101631778B (en) * 2006-07-06 2013-05-08 阵列生物制药公司 Cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
DK2054418T3 (en) 2006-07-06 2012-02-27 Array Biopharma Inc Dihydrothieno-pyrimidines as AKT protein kinase inhibitors
EP2081928B1 (en) * 2006-11-10 2014-02-26 Bristol-Myers Squibb Company Pyrrolo-pyridine kinase inhibitors
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US8071779B2 (en) * 2006-12-18 2011-12-06 Inspire Pharmaceuticals, Inc. Cytoskeletal active rho kinase inhibitor compounds, composition and use
PE15812008A1 (en) 2006-12-21 2008-11-12 Plexxikon Inc COMPOUNDS pyrrolo [2,3-b] pyridines KINASE MODULATORS AS
KR20090091350A (en) 2006-12-21 2009-08-27 버텍스 파마슈티칼스 인코포레이티드 5-cyano-4-(pyrolo[2,3b]pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
CN101641351A (en) 2006-12-21 2010-02-03 普莱希科公司 Compounds and methods for kinase modulation, and indications therefor
WO2008079909A1 (en) 2006-12-21 2008-07-03 Plexxikon, Inc. Pyrrolo [2,3-b] pyridines as kinase modulators
EP2121692B1 (en) 2006-12-22 2013-04-10 Incyte Corporation Substituted heterocycles as janus kinase inhibitors
WO2008084861A1 (en) 2007-01-12 2008-07-17 Astellas Pharma Inc. Condensed pyridine compound
CA2681516A1 (en) * 2007-03-22 2008-09-25 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of janus kinases
WO2008145681A2 (en) 2007-05-31 2008-12-04 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists and uses thereof
GB0710528D0 (en) * 2007-06-01 2007-07-11 Glaxo Group Ltd Novel compounds
CN101932582B (en) 2007-06-13 2013-09-25 因塞特公司 Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CL2008001709A1 (en) 2007-06-13 2008-11-03 Incyte Corp derivatives pyrrolo [2,3-b] pyrimidine, modulators JAK kinases; pharmaceutical composition; and use in the treatment of diseases such as cancer, psoriasis, rheumatoid arthritis, among others.
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101918373B (en) * 2007-07-05 2013-06-05 阵列生物制药公司 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
US8618097B2 (en) 2007-07-05 2013-12-31 Array Biopharma, Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101808994B (en) 2007-07-17 2013-05-15 普莱希科公司 Compounds and methods for kinase modulation, and indications therefor
ES2394759T3 (en) 2008-01-08 2013-02-05 Array Biopharma, Inc. Pyrrolopyridines as kinase inhibitors
KR101624753B1 (en) * 2008-01-09 2016-05-26 어레이 바이오파마 인크. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
EP2240455B1 (en) * 2008-01-09 2012-12-26 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
CA2711741A1 (en) * 2008-01-09 2009-07-16 Array Biopharma Inc. Pyrazolopyridines as kinase inhibitors
GB0801416D0 (en) * 2008-01-25 2008-03-05 Piramed Ltd Pharmaceutical compounds
WO2009145814A2 (en) * 2008-03-10 2009-12-03 Vertex Pharmaceuticals Incorporated Pyrimidines and pyridines useful as inhibitors of protein kinases
MY165582A (en) 2008-03-11 2018-04-05 Incyte Holdings Corp Azetidine and cyclobutane derivatives as jak inhibitors
GB0804592D0 (en) * 2008-03-12 2008-04-16 Glaxo Group Ltd Novel compounds
AR071717A1 (en) 2008-05-13 2010-07-07 Array Biopharma Inc Pyrrolo [2,3-b] pyridines inhibiting kinases Chk1 and Chk2 of, pharmaceutical compositions containing them, process for preparing them and use thereof in treating and preventing cancer.
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
CN104610230A (en) * 2008-06-16 2015-05-13 田纳西大学研究基金会 Compounds for the treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
TWI643622B (en) * 2008-10-02 2018-12-11 英塞特控股公司 Janus for the treatment of dry eye and other ocular diseases related kinase inhibitor
DE102008052943A1 (en) 2008-10-23 2010-04-29 Merck Patent Gmbh azaindole derivatives
EP2816040B1 (en) 2008-12-19 2018-10-17 Centrexion Therapeutics Corporation Process for the production of CCR2 receptor antagonists and intermediates thereof
CN105237530A (en) 2009-04-03 2016-01-13 豪夫迈罗氏公司 Propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide compositions and uses thereof
MY156727A (en) * 2009-05-22 2016-03-15 Incyte Corp N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
PE03712012A1 (en) * 2009-05-22 2012-05-17 Incyte Corp 3- [4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl] heptane-nitrile or octane as JAK inhibitors
NZ597059A (en) 2009-06-17 2014-01-31 Vertex Pharma Inhibitors of influenza viruses replication
TW201105674A (en) 2009-07-08 2011-02-16 Leo Pharma As Novel JAK receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof
TWI466885B (en) * 2009-07-31 2015-01-01 Japan Tobacco Inc Nitrogen-containing spiro cyclic compounds and pharmaceutical use thereof
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
EP2461869B1 (en) * 2009-08-06 2013-08-21 Merck Patent GmbH Novel bicyclic urea compounds
CA2770155C (en) * 2009-08-07 2017-09-19 Merck Patent Gmbh Novel azaheterocyclic compounds
CA2771594C (en) 2009-08-20 2018-05-01 Karus Therapeutics Limited Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
TW201113285A (en) * 2009-09-01 2011-04-16 Incyte Corp Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
BR112012005382A2 (en) 2009-09-10 2016-03-29 Hoffmann La Roche inhibitors of JAK
KR101921850B1 (en) 2009-10-09 2018-11-23 인사이트 홀딩스 코포레이션 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
ES2633317T3 (en) 2009-11-06 2017-09-20 Plexxikon, Inc. Compounds and methods for modulating kinases, and indications for it
CN102933579B (en) 2009-12-17 2015-07-15 贝林格尔.英格海姆国际有限公司 New ccr2 receptor antagonists and uses thereof
EA023444B1 (en) * 2010-02-18 2016-06-30 Инсайт Холдингс Корпорейшн Cyclobutane and methylcyclobutane derivatives, composition based thereon and methods of use thereof
KR101939704B1 (en) 2010-03-01 2019-01-17 지티엑스, 인코포레이티드 Compounds for treatment of cancer
PL3050882T3 (en) * 2010-03-10 2018-08-31 Incyte Holdings Corporation Piperidin-4-yl azetidine derivatives as jak1 inhibitors
JP2013526507A (en) 2010-05-12 2013-06-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング New ccr2 receptor antagonists, their use as their preparation and drugs
JP5646736B2 (en) 2010-05-12 2014-12-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング New ccr2 receptor antagonists, their use as these production methods, and drug
EP2397482A1 (en) * 2010-06-15 2011-12-21 Almirall, S.A. Heteroaryl imidazolone derivatives as jak inhibitors
WO2012068440A1 (en) 2010-11-19 2012-05-24 Incyte Corporation Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
NZ611151A (en) * 2010-11-19 2015-06-26 Incyte Corp Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
CA2822057A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP2014501772A (en) 2011-01-07 2014-01-23 レオ ファーマ アクティーゼルスカブ New sulfamide piperazine derivatives and their pharmaceutical use as protein tyrosine kinase inhibitors
ES2696023T3 (en) 2011-02-07 2019-01-11 Plexxikon Inc Compounds and methods for the modulation of kinases and indications for this
KR20140082591A (en) 2011-02-18 2014-07-02 노파르티스 파르마 아게 mTOR/JAK INHIBITOR COMBINATION THERAPY
TWI558702B (en) 2011-02-21 2016-11-21 Plexxikon Inc Solid forms of a pharmaceutically active substance
SG194048A1 (en) 2011-04-01 2013-11-29 Genentech Inc Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
NZ617243A (en) 2011-04-01 2016-02-26 Genentech Inc Combinations of akt and mek inhibitor compounds, and methods of use
US8691807B2 (en) 2011-06-20 2014-04-08 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
BR112014000115A2 (en) 2011-07-05 2016-10-04 Vertex Pharma processes and intermediates for the production of aza indoles and their solid forms
GEP201706698B (en) 2011-08-01 2017-07-10 Vertex Pharma Inhibitors of influenza viruses replication
EP2741747A1 (en) 2011-08-10 2014-06-18 Novartis Pharma AG JAK P13K/mTOR COMBINATION THERAPY
TW201313721A (en) 2011-08-18 2013-04-01 Incyte Corp Cyclohexyl azetidine derivatives as JAK inhibitors
EP2753621B1 (en) 2011-09-07 2015-12-09 Incyte Holdings Corporation Processes and intermediates for making a jak inhibitor
GB201204125D0 (en) 2012-03-08 2012-04-25 Karus Therapeutics Ltd Compounds
EP2831080B1 (en) 2012-03-29 2017-03-15 Francis Xavier Tavares Lactam kinase inhibitors
WO2013173720A1 (en) 2012-05-18 2013-11-21 Incyte Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
WO2014013014A1 (en) 2012-07-18 2014-01-23 Fundació Privada Centre De Regulació Genòmica (Crg) Jak inhibitors for activation of epidermal stem cell populations
AU2013343291B2 (en) 2012-11-07 2018-05-10 Karus Therapeutics Ltd Novel histone deacetylase inhibitors and their use in therapy
AU2013344780B2 (en) 2012-11-15 2018-03-01 Incyte Holdings Corporation Sustained-release dosage forms of ruxolitinib
FR3001219A1 (en) * 2013-01-22 2014-07-25 Centre Nat Rech Scient Kinase inhibitors
EP2964225B1 (en) * 2013-03-06 2018-08-08 Allosteros Therapeutics Inc. CaMKII INHIBITORS AND USES THEREOF
SG10201707259PA (en) 2013-03-06 2017-10-30 Incyte Corp Processes and intermediates for making a jak inhibitor
CN108283644A (en) 2013-03-15 2018-07-17 G1治疗公司 Transient protection of normal cells during chemotherapy
US9617260B2 (en) * 2013-04-02 2017-04-11 Hoffmann-La Roche Inc. Inhibitors of bruton's tyrosine kinase
ES2688815T3 (en) 2013-05-10 2018-11-07 Karus Therapeutics Limited Histone deacetylase inhibitors novel
US9655854B2 (en) 2013-08-07 2017-05-23 Incyte Corporation Sustained release dosage forms for a JAK1 inhibitor
KR20160084466A (en) 2013-11-13 2016-07-13 버텍스 파마슈티칼스 인코포레이티드 Methods of preparing inhibitors of influenza viruses replication
JP2016537346A (en) 2013-11-13 2016-12-01 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Inhibitors of the replication of the influenza virus
CN105980383B (en) * 2014-02-04 2017-07-04 大鹏药品工业株式会社 Azaindole derivatives
GB201402431D0 (en) 2014-02-12 2014-03-26 Karus Therapeutics Ltd Compounds
EP2924026A1 (en) 2014-03-28 2015-09-30 Novartis Tiergesundheit AG Aminosulfonylmethylcyclohexanes as JAK inhibitors
WO2015161283A1 (en) 2014-04-17 2015-10-22 G1 Therapeutics, Inc. Tricyclic lactams for use in hspc-sparing treatments for rb-positive abnormal cellular proliferation
US9879017B2 (en) * 2014-05-28 2018-01-30 Astrazeneca Ab Processes for the preparation of AZD5363 and intermediate used therein
US9498467B2 (en) 2014-05-30 2016-11-22 Incyte Corporation Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1
EP3183248A1 (en) * 2014-08-21 2017-06-28 Bristol-Myers Squibb Company Tied-back benzamide derivatives as potent rock inhibitors
EP3191098A4 (en) 2014-09-12 2018-04-25 G1 Therapeutics, Inc. Combinations and dosing regimes to treat rb-positive tumors
CN105837572B (en) * 2015-02-02 2019-04-19 四川大学 N- substituted-phenyl amide derivatives and its preparation method and application
JP2018515527A (en) 2015-05-13 2018-06-14 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated Inhibitors of the replication of the influenza virus
CA2990460A1 (en) 2015-07-02 2017-01-05 Centrexion Therapeutics Corporation (4-((3r,4r)-3-methoxytetrahydro-pyran-4-ylamino)piperidin-1-yl)(5-methyl-6-(((2r,6s)-6-(p-tolyl)tetrahydro-2h-pyran-2-yl)methylamino)pyrimidin-4-yl)methanone citrate
CN106928252A (en) * 2015-12-31 2017-07-07 成都先导药物开发有限公司 Compound for inhibiting ROCK (Rho-associated coiled-coil containing protein kinase), and preparation method and application of compound
WO2018041989A1 (en) 2016-09-02 2018-03-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for diagnosing and treating refractory celiac disease type 2
EP3421464A1 (en) * 2017-06-30 2019-01-02 Beijing Tide Pharmaceutical Co., Ltd. Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof
CN109535164A (en) * 2017-09-21 2019-03-29 上海华汇拓医药科技有限公司 Jak kinase inhibitor and preparation method thereof and application in field of medicaments

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5994341A (en) 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
PE03062001A1 (en) * 1999-07-02 2001-03-29 Agouron Pharma Indazole compounds and pharmaceutical compositions containing them useful for the inhibition of protein kinase
CA2395593C (en) 1999-12-24 2011-08-02 Aventis Pharma Limited Azaindoles
AU4878601A (en) * 2000-04-20 2001-11-07 Mitsubishi Corporation Aromatic amide compounds
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
AU2001295986B2 (en) 2000-10-20 2006-08-17 Eisai R&D Management Co., Ltd Nitrogenous aromatic ring compounds
GB0115109D0 (en) 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
GB0202679D0 (en) 2002-02-05 2002-03-20 Glaxo Group Ltd Novel compounds
EP1506189A1 (en) * 2002-04-26 2005-02-16 Vertex Pharmaceuticals Incorporated Pyrrole derivatives as inhibitors of erk2 and uses thereof
AU2003278088A1 (en) 2002-10-28 2004-05-25 Bayer Healthcare Ag Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
GB0227240D0 (en) 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
US7226919B2 (en) * 2002-12-18 2007-06-05 Vertex Pharmaceuticals Inc. Compositions useful as inhibitors of protein kinases
WO2004072063A1 (en) * 2003-02-07 2004-08-26 Vertex Pharmaceuticals Incorporated Heteroaryl substituted pyrolls useful as inhibitors of protein kinases
MXPA05008441A (en) * 2003-02-14 2005-10-19 Wyeth Corp Heterocyclyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands.
US7531553B2 (en) 2003-03-21 2009-05-12 Amgen Inc. Heterocyclic compounds and methods of use
SE0301372D0 (en) * 2003-05-09 2003-05-09 Astrazeneca Ab Novel compounds
US20050043346A1 (en) * 2003-08-08 2005-02-24 Pharmacia Italia S.P.A. Pyridylpyrrole derivatives active as kinase inhibitors
TWI339206B (en) * 2003-09-04 2011-03-21 Vertex Pharma Compositions useful as inhibitors of protein kinases
EP1684694A2 (en) * 2003-11-21 2006-08-02 Array Biopharma, Inc. Akt protein kinase inhibitors
WO2005062795A2 (en) * 2003-12-19 2005-07-14 Plexxikon, Inc. Compounds and methods for development of ret modulators
KR101216372B1 (en) 2004-03-30 2013-01-04 버텍스 파마슈티칼스 인코포레이티드 Azaindoles useful as inhibitors of JAK and other protein kinases
WO2005103050A2 (en) * 2004-04-02 2005-11-03 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of rock and other protein kinases
DE102004020570A1 (en) * 2004-04-27 2005-11-24 Bayer Healthcare Ag substituted Phenylaminopyrimidine
ES2505090T3 (en) 2004-05-07 2014-10-09 Amgen Inc. Nitrogenous heterocyclic derivatives as modulators of protein kinases and their use for treating cancer and angiogenesis
US20060122213A1 (en) * 2004-06-30 2006-06-08 Francoise Pierard Azaindoles useful as inhibitors of protein kinases
BRPI0514094A (en) 2004-08-02 2008-05-27 Osi Pharm Inc compound, composition, and method of treatment of hyperproliferative disorder
AU2005279795A1 (en) * 2004-09-03 2006-03-09 Plexxikon, Inc. Bicyclic heteroaryl PDE4B inhibitors
KR101331786B1 (en) 2004-09-22 2013-11-21 얀센 파마슈티카 엔.브이. Inhibitors of the interaction between mdm2 and p53
DE602005023333D1 (en) * 2004-10-15 2010-10-14 Takeda Pharmaceutical kinase inhibitors
UY29177A1 (en) * 2004-10-25 2006-05-31 Astex Therapeutics Ltd Substituted derivatives of purine, deazapurine and purinone, compositions containing them and methods for their preparation uses
UY29176A1 (en) * 2004-10-25 2006-05-31 Astex Therapeutics Ltd Substituted derivatives of purine, deazapurine and purinone, compositions containing them, methods for their preparation and their uses.
AT482213T (en) * 2004-11-04 2010-10-15 Vertex Pharma As inhibitors of protein kinases suitable pyrazoloä1,5-aüpyrimidine
US7511056B2 (en) * 2004-11-10 2009-03-31 Eli Lilly And Company TGF-β inhibitors
AU2005309566A1 (en) * 2004-11-22 2006-06-01 Vertex Pharmaceuticals Incorporated Bicyclic inhibitors or Rho kinase
AR054416A1 (en) * 2004-12-22 2007-06-27 Incyte Corp Pyrrolo [2,3-b] pyridin-4-yl-amines and pyrrolo [2,3-b] pyrimidin-4-yl-amines as inhibitors of janus kinases. pharmaceutical compositions.
MX2007007797A (en) * 2004-12-27 2007-08-23 Alcon Inc Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases.
GB0501999D0 (en) * 2005-02-01 2005-03-09 Sentinel Oncology Ltd Pharmaceutical compounds
KR20070104641A (en) * 2005-02-03 2007-10-26 버텍스 파마슈티칼스 인코포레이티드 Pyrrolopyrimidines useful as inhibitors of protein kinase
JP2008540664A (en) * 2005-05-16 2008-11-20 アイアールエム・リミテッド・ライアビリティ・カンパニーIrm,Llc Pyrrolopyridine derivatives as protein kinase inhibitors
EP1881983B1 (en) * 2005-05-20 2012-01-11 Vertex Pharmaceuticals, Inc. Pyrrolopyridines useful as inhibitors of protein kinase
KR20080063809A (en) * 2005-09-30 2008-07-07 버텍스 파마슈티칼스 인코포레이티드 Deazapurines useful as inhibitors of janus kinases
AR060316A1 (en) * 2006-01-17 2008-06-11 Vertex Pharma Azaindoles useful as inhibitors of Janus kinases
WO2007084667A2 (en) * 2006-01-19 2007-07-26 Osi Pharmaceutical, Inc. Fused heterobicyclic kinase inhibitors
US8741912B2 (en) 2006-04-05 2014-06-03 Vertex Pharmaceuticals Incorporated Deazapurines useful as inhibitors of Janus kinases
KR20090091350A (en) * 2006-12-21 2009-08-27 버텍스 파마슈티칼스 인코포레이티드 5-cyano-4-(pyrolo[2,3b]pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors
NZ597059A (en) * 2009-06-17 2014-01-31 Vertex Pharma Inhibitors of influenza viruses replication
RU2013132683A (en) * 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед inhibitors of influenza virus replication
GEP201706698B (en) * 2011-08-01 2017-07-10 Vertex Pharma Inhibitors of influenza viruses replication

Also Published As

Publication number Publication date
CN101228161B (en) 2012-10-10
KR20080016659A (en) 2008-02-21
RU2435769C2 (en) 2011-12-10
AU2006251623A1 (en) 2006-11-30
RU2007147455A (en) 2009-06-27
NZ564065A (en) 2011-03-31
CN101228161A (en) 2008-07-23
NO20076502L (en) 2008-02-19
JP2013253114A (en) 2013-12-19
RU2011133825A (en) 2013-02-20
WO2006127587A1 (en) 2006-11-30
AT540948T (en) 2012-01-15
EP1881983A1 (en) 2008-01-30
EP2354140A1 (en) 2011-08-10
CA2609126A1 (en) 2006-11-30
EP1881983B1 (en) 2012-01-11
JP2008545660A (en) 2008-12-18
ES2380795T3 (en) 2012-05-18
US20070135466A1 (en) 2007-06-14
ZA200710379B (en) 2009-05-27
US8921376B2 (en) 2014-12-30
EP2354139A1 (en) 2011-08-10
JP2009179644A (en) 2009-08-13
MX2007014619A (en) 2009-02-13

Similar Documents

Publication Publication Date Title
TWI353983B (en) Aromatic compound and pharmaceutical composition c
TWI312682B (en) Heteroaromatic quinoline compounds and pharmaceutical compositions comprising the same
GB2389530B (en) Pharmaceutical compositions
TWI427077B (en) Pyrazole compound and use thereof and pharmaceutical composition containing the same
EP1551402A4 (en) Abuse-resistant pharmaceutical compositions
IL206831A (en) Glucopyranosyl derivatives and pharmaceutical compositions containing the same and uses thereof
IL170758D0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
IL164187D0 (en) 7-Azaindole derivatives and pharmaceutical compositions containing the same
IL162548A (en) 4-oxoquinoline derivatives and pharmaceutical compositions containing the same
IL191623D0 (en) Fused heterocyclic compounds and pharmaceutical compositions containing the same
IL192298A (en) Heterocyclic compounds, pharmaceutical acceptable salts thereof, pharmaceutical compositions comprising the same and uses thereof
IL213876D0 (en) Maytansinoid derivatives and pharmaceutical compositions containing the same
IL170636A (en) Quinazoline derivatives and pharmaceutical compositions containing the same
IL187317D0 (en) A polypeptide complex and pharmaceutical compositions containing the same
IL166232D0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
IL203915A (en) 2-benzylphenyl-6-hydroxymethyl-tetrahydro-2h-pyran-3,4,5-triol derivatives and pharmaceutical compositions comprising the same
IL181697D0 (en) Medicinal composition
EP1857489A4 (en) Microparticle and pharmaceutical composition
IL176014D0 (en) Azepinoindole derivatives as pharmaceutical agents
IL174128D0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL186526A (en) Substituted amide derivatives and pharmaceutical compositions comprising them
IL189737D0 (en) Pyrazine derivatives, their preparation and pharmaceutical compositions containing them
IL164082D0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
EP1603593A4 (en) Pharmaceutical composition
IL195488A (en) Compounds, pharmaceutical compositions comprising the same and uses thereof